Improving the Power to Track Fibrillar Amyloid Pet Measurements and Evaluate Amyloid-Modifying Treatments Using a Cerebral White Matter Reference Region-Of-Interest

Alzheimer's and Dementia - United States

doi 10.1016/j.jalz.2014.07.069